Polymeric Nanoparticles as a Promising Drug Delivery Platform for the Efficacious Delivery of Toll-Like Receptor 7/8 Agonists and IDO-Inhibitor

[1]  V. Danilenko,et al.  Identification of Mutations Conferring Tryptanthrin Resistance to Mycobacterium smegmatis , 2020, Antibiotics.

[2]  A. Maugeri,et al.  Three-Year Trends of Healthcare-Associated Infections and Antibiotic Use in Acute Care Hospitals: Findings from 2016–2018 Point Prevalence Surveys in Sicily, Italy , 2020, Antibiotics.

[3]  T. Mehta,et al.  Intranasal delivery of chitosan decorated PLGA core /shell nanoparticles containing flavonoid to reduce oxidative stress in the treatment of Alzheimer's disease , 2020 .

[4]  F. N. Sorasitthiyanukarn,et al.  Evaluation of in vitro release kinetics of Capsaicin-loaded chitosan nanoparticles using DDSolver , 2020 .

[5]  A. Chakraborti,et al.  Formulation, physico-chemical characterization and antidiabetic potential of naringenin-loaded poly D, L lactide-co-glycolide (N-PLGA) nanoparticles , 2020, European Polymer Journal.

[6]  R. Srivastava,et al.  Dual drug delivery of curcumin and niclosamide using PLGA nanoparticles for improved therapeutic effect on breast cancer cells , 2020, Journal of Polymer Research.

[7]  R. Sen,et al.  Gemcitabine Co-Encapsulated with Curcumin in Folate Decorated PLGA Nanoparticles; a Novel Approach to Treat Breast Adenocarcinoma , 2020, Pharmaceutical Research.

[8]  Cindy Alejandra Gutiérrez-Valenzuela,et al.  PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters , 2020, RSC advances.

[9]  Jiaguo Liu,et al.  Rational design of PLGA nanoparticles vaccine delivery systems to improve immune responses. , 2019, Molecular pharmaceutics.

[10]  D. Salunke,et al.  Efficacy of TLR7 agonistic imidazoquinoline as immunochemotherapeutic agent against P. Berghei ANKA infected rodent host. , 2019, Bioorganic & medicinal chemistry letters.

[11]  D. Mcclements,et al.  Design of Astaxanthin-Loaded Core-Shell Nanoparticles Consisting of Chitosan Oligosaccharides and Poly(lactic- co-glycolic acid): Enhancement of Water Solubility, Stability, and Bioavailability. , 2019, Journal of agricultural and food chemistry.

[12]  D. Ferguson,et al.  Acidic pH-responsive polymer nanoparticles as a TLR7/8 agonist delivery platform for cancer immunotherapy. , 2018, Nanoscale.

[13]  L. Kováčik,et al.  Molecular Insight into Drug-Loading Capacity of PEG-PLGA Nanoparticles for Itraconazole. , 2018, The journal of physical chemistry. B.

[14]  M. Gradzielski,et al.  Biomimetic Solid Lipid Nanoparticles of Sophorolipids Designed for Antileprosy Drugs. , 2018, The journal of physical chemistry. B.

[15]  E. Allémann,et al.  Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation. , 2018, International journal of pharmaceutics.

[16]  Zhengwei Cai,et al.  Paclitaxel-loaded PLGA microspheres with a novel morphology to facilitate drug delivery and antitumor efficiency , 2018, RSC advances.

[17]  Hassan A Almoustafa,et al.  Technical aspects of preparing PEG-PLGA nanoparticles as carrier for chemotherapeutic ‎agents by nanoprecipitation method. , 2017, International journal of pharmaceutics.

[18]  M. Ramezani,et al.  Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient In Vivo Immune Responses , 2017, Front. Immunol..

[19]  M. Kolev,et al.  Keeping It All Going—Complement Meets Metabolism , 2017, Front. Immunol..

[20]  J. Santamaría,et al.  Dual encapsulation of hydrophobic and hydrophilic drugs in PLGA nanoparticles by a single-step method: drug delivery and cytotoxicity assays , 2016 .

[21]  L. Beilin,et al.  Dual energy X-ray absorptiometry compared with anthropometry in relation to cardio-metabolic risk factors in a young adult population: Is the ‘Gold Standard’ tarnished? , 2016 .

[22]  Asmita Das,et al.  Anthracycline Drugs on Modified Surface of Quercetin-Loaded Polymer Nanoparticles: A Dual Drug Delivery Model for Cancer Treatment , 2016, PloS one.

[23]  Giuseppe Caruso,et al.  Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen , 2016, PloS one.

[24]  T. Arasoglu,et al.  Comparative evaluation of antibacterial activity of caffeic acid phenethyl ester and PLGA nanoparticle formulation by different methods , 2016, Nanotechnology.

[25]  M. Gümüşderelioğlu,et al.  Melatonin releasing PLGA micro/nanoparticles and their effect on osteosarcoma cells , 2016, Journal of microencapsulation.

[26]  S. Davaran,et al.  Triamcinolone acetonide–Eudragit® RS100 nanofibers and nanobeads: Morphological and physicochemical characterization , 2016, Artificial cells, nanomedicine, and biotechnology.

[27]  D. K. Majumdar,et al.  Formulation and characterization of clozapine and risperidone co-entrapped spray-dried PLGA nanoparticles , 2016, Pharmaceutical development and technology.

[28]  B. Mukherjee,et al.  Pulmonary Delivery of Voriconazole Loaded Nanoparticles Providing a Prolonged Drug Level in Lungs: A Promise for Treating Fungal Infection. , 2015, Molecular pharmaceutics.

[29]  Hiroyasu Ito,et al.  Inhibition of indoleamine 2,3‐dioxygenase activity enhances the anti‐tumour effects of a Toll‐like receptor 7 agonist in an established cancer model , 2015, Immunology.

[30]  Qian Xu,et al.  TPGS2k/PLGA nanoparticles for overcoming multidrug resistance by interfering mitochondria of human alveolar adenocarcinoma cells. , 2015, ACS applied materials & interfaces.

[31]  Yazhou Wang,et al.  Dual drug release from core-shell nanoparticles with distinct release profiles. , 2014, Journal of pharmaceutical sciences.

[32]  Guangjun Nie,et al.  Applications of nanomaterials as vaccine adjuvants , 2014, Human vaccines & immunotherapeutics.

[33]  G. Prendergast,et al.  Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer , 2014, Cancer Immunology, Immunotherapy.

[34]  Qing Yang,et al.  Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice. , 2013, Journal of medicinal chemistry.

[35]  Amit Jain,et al.  Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity. , 2013, Molecular pharmaceutics.

[36]  J. Wolchok,et al.  Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4 , 2013, The Journal of experimental medicine.

[37]  M. Colombo,et al.  Intracellular drug release from curcumin-loaded PLGA nanoparticles induces G2/M block in breast cancer cells. , 2013, Biomacromolecules.

[38]  T. Maekawa,et al.  Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer's Disease , 2012, PloS one.

[39]  K. Sawant,et al.  Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. , 2011, Acta biomaterialia.

[40]  M. Pallardy,et al.  Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells. , 2011, Biomacromolecules.

[41]  Fengyi Zhang,et al.  PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. , 2011, Journal of agricultural and food chemistry.

[42]  Yu-Han Su,et al.  Tryptanthrin-loaded nanoparticles for delivery into cultured human breast cancer cells, MCF7: the effects of solid lipid/liquid lipid ratios in the inner core. , 2011, Chemical & pharmaceutical bulletin.

[43]  Chandan Thomas,et al.  Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine. , 2011, Molecular pharmaceutics.

[44]  S. Adams.  Toll-like receptor agonists in cancer therapy. , 2009, Immunotherapy.

[45]  Xiangrong Song,et al.  Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[46]  S. Feng,et al.  In vitro investigation on poly(lactide)-Tween 80 copolymer nanoparticles fabricated by dialysis method for chemotherapy. , 2006, Biomacromolecules.

[47]  K. Kosmidis,et al.  On the use of the Weibull function for the discernment of drug release mechanisms. , 2006, International journal of pharmaceutics.

[48]  S. Feng,et al.  Study on surfactant coating of polymeric nanoparticles for controlled delivery of anticancer drug , 2004 .

[49]  B. Jenkins,et al.  TLR Agonists as Adjuvants for Cancer Vaccines. , 2017, Advances in experimental medicine and biology.